NCT04785105

Brief Summary

The aim of this study was to evaluate asymptomatic superior mesenteric artery (SMA) stenosis prognosis according to the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2020

Completed
9 months until next milestone

First Posted

Study publicly available on registry

March 5, 2021

Completed
Last Updated

March 5, 2021

Status Verified

June 1, 2020

Enrollment Period

2.8 years

First QC Date

June 22, 2020

Last Update Submit

March 4, 2021

Conditions

Keywords

SMAStenosisStenosis on scanner

Outcome Measures

Primary Outcomes (1)

  • Development of mesenteric disease defined as acute mesenteric ischemia or chronic mesenteric ischemia.

    4 years

Study Arms (2)

patient with isolated SMA stenosis

patient with isolated SMA stenosis on initial scanner

Other: No intervention

patient with both SMA stenosis and CA or/and IMA stenosis

patient with both SMA stenosis and CA or/and IMA stenosis on initial scanner

Other: No intervention

Interventions

No intervention

patient with both SMA stenosis and CA or/and IMA stenosispatient with isolated SMA stenosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* patients with isolated \>70% SMA stenosis * patients with both SMA stenosis and CA or/and IMA \>70% stenosis

You may qualify if:

  • the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupement Hospitalier Est

Bron, 69500, France

Location

MeSH Terms

Conditions

Constriction, Pathologic

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2020

First Posted

March 5, 2021

Study Start

February 1, 2017

Primary Completion

December 1, 2019

Study Completion

March 1, 2020

Last Updated

March 5, 2021

Record last verified: 2020-06

Locations